Above products are not available in patent covered areas, or only used for laboratory research and development.
*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Abiraterone acetate is a potent oral inhibitor of <strong>CYP17A1</strong>, an enzyme critical for androgen biosynthesis. Synthesized via chemical acetylation, its molecular formula is C<sub>23</sub>H<sub>30</sub>O<sub>3</sub> with CAS No. 154229-19-3.</p>
<h3>Application</h3>
<ul>
<li><strong>Oncology:</strong> First-line treatment for metastatic castration-resistant prostate cancer (mCRPC).</li>
<li><strong>Endocrinology:</strong> Management of hormone-dependent tumors requiring androgen suppression.</li>
</ul>
<h3>Precautions</h3>
<p>Mandatory co-administration with prednisone is required to prevent mineralocorticoid excess. Store in tightly sealed containers at controlled room temperature (20-25°C) away from moisture and light. Handle with appropriate PPE due to potential reproductive toxicity.</p>